| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8735297 | Hepatobiliary & Pancreatic Diseases International | 2017 | 6 Pages |
Abstract
The delayed introduction of immunosuppressive regimens is safe and effective in management of critically ill patients after liver transplantation. The serial ImmuKnow assay could provide a reliable depiction of the dynamics of functional immunity throughout the clinical course of a given patient.
Related Topics
Health Sciences
Medicine and Dentistry
Hepatology
Authors
Ying Luo, Wen-Bin Ji, Wei-Dong Duan, Xian-Jie Shi, Zhi-Ming Zhao,